European patent office decides in Synthon’s favor in glatiramer patent case. In opposition proceedings filed by inter alia Synthon, the Technical Board of Appeal (TBA) of the European Patent Office revoked the last of Teva’s three glatiramer so-called HBr patents which claimed an allegedly improved process for the synthesis of glatiramer acetate. This decision clears the…
Selvita Opens New Office in U.S.
Selvita, the largest drug discovery company in Central and Eastern Europe, has just opened its West Coast U.S. office, located in San Bruno, CA. Selvita has initiated its U.S. operations in September 2015, opening a fully-owned U.S. subsidiary, Selvita Inc., headquartered in Cambridge, MA. Now, the company is officially opening its second office, which is…
CDMO Vetter Wins Two Awards
Selvita Opens New Research Site
Selvita, a drug discovery company in Central and Eastern Europe, has signed a contract for the lease of laboratory space in Poznan, Poland. The new site will be located at in the Wielkopolska Centre of Advanced Technologies and commence research activities in the summer of 2016. The initial laboratory space will amount to 5,500 sq. feet,…
Sartorius Launches Online Resource Center for Single-Use Bioprocesses
New website will support clients in developing and implementing entire single-use bioprocesses. Sartorius Stedim Biotech, an international leading supplier for the biopharmaceutical industry, today announced the launch of its Integrated Solutions website, an online resource and information centre to support its clients as they develop and implement entire single-use or hybrid biomanufacturing processes. The new…